Free tool
Diagnostics stocks
We cover 89 companies grouped under the Diagnostics theme. The median market value in the group is $30.10M. Across the group, the median move over the past trading day is 0.00%. 42% of the 88 with a 200-day average trade above it. Price change over the past year runs from −83.9% to +99.7% across the middle 80 percent of the group, with a median of −16.4%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
89 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| SHL.AX | Sonic Healthcare Limited | 20.12 AUD | −11.44% | −8.60% | −11.84% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| 6678.T | Techno Medica Co., Ltd. | 2,112.00 JPY | +3.63% | −0.76% | +12.34% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.96 BRL | −8.36% | −36.34% | −52.03% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.80 AUD | +23.26% | −3.64% | +47.22% |
| SERA | Sera Prognostics, Inc. | $2.09 | +2.96% | −30.33% | −26.41% |
| MDXH | MDxHealth SA | $0.76 | +83.97% | −77.96% | −84.51% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.10 AUD | 0.00% | −68.75% | −25.93% |
| DXR | Daxor Corporation | $10.03 | −5.87% | −30.19% | −11.60% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| CYC.AX | Cyclopharm Limited | 0.52 AUD | −13.11% | −47.51% | −48.30% |
| BIOBV.HE | Biohit Oyj | 2.60 EUR | −6.14% | −27.78% | −8.13% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| PAVM | PAVmed Inc. | $5.32 | −1.12% | −27.42% | −63.21% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| 2385.T | Soiken Holdings Inc. | 224.00 JPY | +3.70% | −5.49% | +17.28% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| COV.AX | Cleo Diagnostics Ltd | 0.35 AUD | +12.90% | −43.09% | +4.48% |
| ACARIX.ST | Acarix AB (publ) | 0.24 SEK | −3.99% | −10.93% | −14.11% |
| NXN.AX | Nexsen Ltd | 0.21 AUD | −12.50% | +40.00% | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | 0.31 CAD | −1.61% | +27.08% | +27.08% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| MAP.AX | Microba Life Sciences Limited | 0.06 AUD | +17.02% | −28.57% | −42.11% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| ALIKO.PA | Ikonisys S.A. | 1.42 EUR | −5.33% | −12.07% | −6.58% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +23.46% | −20.00% | 0.00% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| 6090.T | Human Metabolome Technologies, Inc. | 623.00 JPY | +4.53% | −7.01% | −16.38% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +10.00% | −77.08% | −48.44% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ALBIO.PA | Biosynex SA | 0.90 EUR | −0.88% | +56.06% | −23.23% |
| URT.WA | Urteste S.A. | 43.70 PLN | −6.42% | +2.82% | −15.31% |
| BDX.AX | BCAL Diagnostics Limited | 0.06 AUD | −17.81% | −40.00% | −6.25% |
| IIQ.AX | INOVIQ Ltd | 0.17 AUD | −12.82% | −57.50% | −58.54% |
| GMT.WA | Genomtec S.A. | 3.68 PLN | −8.80% | −2.39% | −40.65% |
| ADVB | Advanced Biomed Inc. | $9.24 | −15.07% | +52.98% | +13.24% |
| GSS.AX | Genetic Signatures Limited | 0.09 AUD | +50.00% | −64.49% | −71.00% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| TRI.AX | TrivarX Limited | 0.02 AUD | 0.00% | −20.00% | +60.00% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.71% | −17.89% | −20.78% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −5.56% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CODX | Co-Diagnostics, Inc. | $1.25 | −11.35% | −77.52% | −87.22% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| NDRA | ENDRA Life Sciences Inc. | $5.44 | +21.97% | +26.81% | +32.36% |
| AIDX | 20/20 Biolabs, Inc. | $0.56 | +22.39% | −97.64% | −97.64% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| ACON | Aclarion, Inc. | $2.39 | +12.21% | −52.01% | −66.10% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| INBS | Intelligent Bio Solutions Inc. | $2.26 | +41.78% | −71.36% | −85.79% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.93 | +23.72% | −32.04% | −48.46% |
| BMRA | Biomerica, Inc. | $1.69 | +5.62% | −33.21% | −46.35% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| VNRX | VolitionRx Limited | $0.34 | −60.09% | −93.72% | −97.47% |
| REVB | Revelation Biosciences, Inc. | $0.96 | −8.00% | −70.63% | −91.25% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| ADTX | Aditxt, Inc. | $0.00 | −48.00% | −100.00% | −100.00% |
| ONCO | Onconetix, Inc. | $0.64 | −22.77% | −99.20% | −99.56% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| BJDX | Bluejay Diagnostics, Inc. | $0.89 | −10.66% | −65.90% | −83.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.